# Catabasis Pharmaceuticals, Inc. (CATB)

Source: https://www.quantisnow.com/company/CATB
Generated: 2026-11-10T08:18:34.922Z

- Ticker: CATB
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Major Pharmaceuticals
- IPO year: 2015
- Website: catabasis.com

## About

Catabasis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics in the United States. The company's lead product candidate is QLS-215, a monoclonal antibody inhibitor of plasma kallikrein that is in preclinical development for the treatment of hereditary angioedema, a rare, debilitating and potentially life-threatening disease. The company was incorporated in 2008 and is based in Boston, Massachusetts.

## Latest CATB news and filings

- 2021-09-23 01:54 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Catabasis Pharmaceuticals, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-catabasis-pharmaceuticals-inc-amendment-1801515)
- 2021-09-22 21:00 UTC [SEC Form 4] [SEC Form 4 filed by Violin Jonathan](https://www.quantisnow.com/insight/sec-form-4-filed-by-violin-jonathan-1800541)
- 2021-09-22 19:57 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Catabasis Pharmaceuticals, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-catabasis-pharmaceuticals-inc-amendment-1799968)
- 2021-09-08 21:31 UTC [SEC Form 8-K] [Catabasis Pharmaceuticals, Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/catabasis-pharmaceuticals-inc-filed-sec-form-8-k-amendments-to-articles-1752541)
- 2021-09-08 12:00 UTC [Catabasis Pharmaceuticals Announces New Company Name, Astria Therapeutics, Highlighting New Company Focus](https://www.quantisnow.com/insight/catabasis-pharmaceuticals-announces-new-company-name-astria-therapeutics-highlighting-new-1748890)
- 2021-09-02 11:00 UTC [Analyst Coverage Initiated] [Wedbush initiated coverage on Catabasis Pharmaceuticals with a new price target](https://www.quantisnow.com/insight/wedbush-initiated-coverage-on-catabasis-pharmaceuticals-with-a-new-price-1733729)
- 2021-08-25 10:09 UTC [Analyst Upgrade] [Catabasis Pharmaceuticals upgraded by HC Wainwright & Co. with a new price target](https://www.quantisnow.com/insight/catabasis-pharmaceuticals-upgraded-by-hc-wainwright-co-with-a-new-1705097)
- 2021-08-20 20:01 UTC [SEC Form 8-K] [Catabasis Pharmaceuticals, Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/catabasis-pharmaceuticals-inc-filed-sec-form-8-k-material-modification-to-1693991)
- 2021-08-09 20:11 UTC [SEC Form S-8] [SEC Form S-8 filed by Catabasis Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-catabasis-pharmaceuticals-inc-1645026)
- 2021-08-09 20:10 UTC [Dividends] [Catabasis Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides a Corporate Update](https://www.quantisnow.com/insight/catabasis-pharmaceuticals-reports-second-quarter-2021-financial-results-and-provides-1644880)
- 2021-08-09 20:01 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Catabasis Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-catabasis-pharmaceuticals-inc-1644626)
- 2021-08-04 12:00 UTC [Conference Announcement] [Catabasis Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference](https://www.quantisnow.com/insight/catabasis-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference-1616181)
- 2021-07-09 18:38 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Catabasis Pharmaceuticals, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-catabasis-pharmaceuticals-inc-amendment-1314757)
- 2021-07-07 12:00 UTC [Conference Announcement] [Catabasis Pharmaceuticals To Present At Ladenburg Thalmann 2021 Healthcare Conference](https://www.quantisnow.com/insight/catabasis-pharmaceuticals-to-present-at-ladenburg-thalmann-2021-healthcare-conference-1275487)
- 2021-06-30 20:25 UTC [SEC Form 8-K] [Catabasis Pharmaceuticals, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/catabasis-pharmaceuticals-inc-filed-sec-form-8-k-entry-into-a-1209906)
- 2021-06-30 20:17 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Catabasis Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-catabasis-pharmaceuticals-inc-1209693)
- 2021-06-25 21:01 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Catabasis Pharmaceuticals, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-catabasis-pharmaceuticals-inc-amendment-1156408)
- 2021-06-25 21:01 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Catabasis Pharmaceuticals, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-catabasis-pharmaceuticals-inc-amendment-1156290)
- 2021-06-17 17:41 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by Catabasis Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-catabasis-pharmaceuticals-inc-1055036)
- 2021-06-17 17:32 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Catabasis Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-catabasis-pharmaceuticals-inc-1054880)
- 2021-06-15 20:32 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Catabasis Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-catabasis-pharmaceuticals-inc-1024171)
- 2021-06-10 20:06 UTC [SEC Form 4] [SEC Form 4 filed by Harshbarger Benjamin](https://www.quantisnow.com/insight/sec-form-4-filed-by-harshbarger-benjamin-981758)
- 2021-06-10 20:05 UTC [SEC Form 8-K] [Catabasis Pharmaceuticals, Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events (Amendment)](https://www.quantisnow.com/insight/catabasis-pharmaceuticals-inc-filed-sec-form-8-k-submission-of-matters-981735)
- 2021-06-02 23:19 UTC [SEC Form 4] [SEC Form 4 filed by Komjathy Andrew](https://www.quantisnow.com/insight/sec-form-4-filed-by-komjathy-andrew-946949)
- 2021-06-02 23:18 UTC [SEC Form 4] [SEC Form 4 filed by Nichols Andrew John](https://www.quantisnow.com/insight/sec-form-4-filed-by-nichols-andrew-john-946943)
- 2021-06-02 23:18 UTC [SEC Form 4] [SEC Form 4 filed by Callori Fred](https://www.quantisnow.com/insight/sec-form-4-filed-by-callori-fred-946940)
- 2021-06-02 23:17 UTC [SEC Form 4] [SEC Form 4 filed by Violin Jonathan](https://www.quantisnow.com/insight/sec-form-4-filed-by-violin-jonathan-946938)
- 2021-06-02 23:17 UTC [SEC Form 4] [SEC Form 4 filed by Clauser Noah](https://www.quantisnow.com/insight/sec-form-4-filed-by-clauser-noah-946933)
- 2021-06-02 23:16 UTC [SEC Form 4] [SEC Form 4 filed by Catabasis Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-catabasis-pharmaceuticals-inc-946927)
- 2021-06-02 23:16 UTC [SEC Form 4] [SEC Form 4 filed by BATE KENNETH](https://www.quantisnow.com/insight/sec-form-4-filed-by-bate-kenneth-946925)
- 2021-06-02 23:15 UTC [SEC Form 4] [SEC Form 4 filed by Beck Joanne T.](https://www.quantisnow.com/insight/sec-form-4-filed-by-beck-joanne-t-946923)
- 2021-06-02 23:14 UTC [SEC Form 4] [SEC Form 4 filed by Catabasis Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-catabasis-pharmaceuticals-inc-946921)
- 2021-06-02 23:15 UTC [SEC Form 4] [SEC Form 4 filed by Catabasis Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-catabasis-pharmaceuticals-inc-946920)
- 2021-06-02 23:13 UTC [SEC Form 4] [SEC Form 4 filed by Catabasis Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-catabasis-pharmaceuticals-inc-946914)
- 2021-06-02 23:13 UTC [SEC Form 4] [SEC Form 4 filed by Harshbarger Benjamin](https://www.quantisnow.com/insight/sec-form-4-filed-by-harshbarger-benjamin-946911)
- 2021-06-02 20:05 UTC [SEC Form 8-K] [Catabasis Pharmaceuticals, Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/catabasis-pharmaceuticals-inc-filed-sec-form-8-k-leadership-update-submission-942463)
- 2021-05-14 12:00 UTC [Conference Announcement] [Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences](https://www.quantisnow.com/insight/catabasis-pharmaceuticals-to-present-at-upcoming-investor-conferences-742551)
- 2021-05-13 20:10 UTC [Catabasis Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides a Corporate Update](https://www.quantisnow.com/insight/catabasis-pharmaceuticals-reports-first-quarter-2021-financial-results-and-provides-740319)
- 2021-05-13 20:06 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Catabasis Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-catabasis-pharmaceuticals-inc-740271)
- 2021-05-12 11:34 UTC [Analyst Coverage Initiated] [Ladenburg Thalmann initiated coverage on Catabasis Pharmaceuticals with a new price target](https://www.quantisnow.com/insight/ladenburg-thalmann-initiated-coverage-on-catabasis-pharmaceuticals-with-a-new-733929)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CATB
- Earnings history: https://www.quantisnow.com/earnings/CATB
- Dividend history: https://www.quantisnow.com/dividends/CATB
- Insider transactions: https://www.quantisnow.com/insiders/CATB
- Options chain: https://www.quantisnow.com/options/CATB
- SEC 8-K filings only: https://www.quantisnow.com/company/CATB/8-k
- RSS and alerts for CATB: https://www.quantisnow.com/docs/rss-feeds.md